
Cefrazen TZ 250mg/31.25mg Injection
Marketer
Zennar Life Sciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cefrazen TZ 250mg/31.25mg Injection
The dual-action injectable medication, Cefrazen TZ 250mg/31.25mg, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under a healthcare provider's guidance; strictly adhere to the prescribed schedule, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms require immediate medical attention. Seek immediate medical assistance for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are crucial for optimal recovery. Your doctor may order lab tests and imaging to monitor treatment response.
Primary Ingredients of Cefrazen TZ 250mg/31.25mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Cefrazen TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cefrazen TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Cefrazen TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefrazen TZ 250mg/31.25mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
How Cefrazen TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Cefrazen TZ 250mg/31.25mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, thereby hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, complements this action by countering bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Cefrazen TZ 250mg/31.25mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
Cefrazen TZ 250mg/31.25mg injections are typically deemed safe for pregnant individuals. Preclinical trials using animals have revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Cefrazen TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Cefrazen TZ 250mg/31.25mg Injection may induce drowsiness, visual disturbances, or dizziness. Operating a vehicle is contraindicated if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefrazen TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable formulation of Cefrazen TZ 250mg/31.25mg requires careful administration for individuals with significant hepatic impairment. Dosage modification may be necessary; physician consultation is advised. Altering the dose of Cefrazen TZ 250mg/31.25mg Injection is generally not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefrazen TZ 250mg/31.25mg Injection :
Omitting a scheduled dose of Cefrazen TZ 250mg/31.25mg Injection warrants immediate physician consultation.
Facts to Know About Cefrazen TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
